CAS: 1627696-53-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | LY3143921 hydrate REF: 54-BUP01191CAS: 1627696-53-0 | 98.42% | 348.00 €~792.00 € | Mon 21 Apr 25 |
 | LY3143921 hydrate REF: 3D-CQC69653CAS: 1627696-53-0 | Min. 95% | To inquire | Thu 29 May 25 |
 | LY3143921 hydrate REF: TM-T9064CAS: 1627696-53-0 | 98.43% | 49.00 €~532.00 € | Thu 31 Jul 25 |
Ref: 54-BUP01191
| 25mg | 348.00 € | ||
| 50mg | 518.00 € | ||
| 100mg | 792.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
LY3143921 hydrate
CAS:1627696-53-0
Please enquire for more information about LY3143921 hydrate including the price, delivery time and more …
Formula:
C16H14FN5O2
Purity:
Min. 95%
Molecular weight:
327.31 g/mol
Ref: 3D-CQC69653
| 25mg | 1,262.00 € | ||
| 50mg | 1,755.00 € |
Estimated delivery in United States, on Thursday 29 May 2025
LY3143921 hydrate
CAS:1627696-53-0
LY3143921 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor with broad in vitro …
Formula:
C16H14FN5O2
Purity:
98.43%
Color and Shape:
Solid
Molecular weight:
327.31
Ref: TM-T9064
| 1mg | 49.00 € | ||
| 5mg | 97.00 € | ||
| 10mg | 140.00 € | ||
| 25mg | 229.00 € | ||
| 50mg | 346.00 € | ||
| 100mg | 532.00 € |
Estimated delivery in United States, on Thursday 31 Jul 2025
